EP3350163
Ein- eða tvísetnar indólafleiður sem beinbrunasóttarveiru eftirmyndunarhemlar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
15.9.2016EP published:
25.12.2019EP application number:
16767235.1
EP translation filed:
4.3.2020Grant published:
15.3.2020EPO information:
European Patent Register
Max expiry date:
14.9.2036Expiry date:
14.9.2023
Title:
MONO- OR DI-SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS
Timeline
Today
15.9.2016EP application
25.12.2019EP Publication
4.3.2020Translation submitted
15.3.2020Registration published
14.9.2023Expires
Owner
Name:
Janssen Pharmaceuticals, Inc.Address:
1125 Trenton-Harbourton Road, Titusville, NJ 08560, US
Name:
Katholieke Universiteit LeuvenAddress:
K.U. Leuven R&D Waaistraat 6 Box 5105, 3000 Leuven, BE
Inventor
Name:
KESTELEYN, Bart Rudolf RomanieAddress:
2340 Beerse, BE
Name:
RABOISSON, Pierre Jean-Marie BernardAddress:
2340 Beerse, BE
Name:
BONFANTI, Jean-FrançoisAddress:
92787 Issy-les-Moulineaux Cedex 9, FR
Name:
JONCKERS, Tim Hugo MariaAddress:
2340 Beerse, BE
Name:
BARDIOT, Dorothée Alice Marie-EveAddress:
3001 Leuven (Heverlee), BE
Name:
MARCHAND, Arnaud Didier MAddress:
3001 Leuven (Heverlee), BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
15185522Date:
16.9.2015Country:
EP
Number:
16163465Date:
1.4.2016Country:
EP
Classification
Categories:
C07D 209/12, A61K 31/454, A61P 31/14
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 6.8.2020
Expires: 14.9.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 10.8.2021
Expires: 14.9.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 16.8.2022
Expires: 14.9.2023
Payer: Árnason Faktor ehf.